Marine peptide sales will grow through 2036, led by fish peptides at a 45.0% share in 2026 as the leading product segment. The market is expected to reach USD 324.3 million in 2026 and USD 569.9 million by 2036, creating an absolute dollar opportunity of USD 245.6 million between 2026 and 2036.